首页> 外文期刊>Archives of Pathology & Laboratory Medicine >A Liquid Concept-Do Classic Preparations of Body Cavity Fluid Perform Differently Than ThinPrep Cases? Observations From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology
【24h】

A Liquid Concept-Do Classic Preparations of Body Cavity Fluid Perform Differently Than ThinPrep Cases? Observations From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology

机译:液体概念-体腔液的经典制剂与ThinPrep盒的性能不同吗?来自美国病理学家学院非妇科学细胞学实验室间比较计划的观察

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

CONTEXT: Newer liquid-based preparations differ morphologically from classic preparations (smears, filters, and cytocentrifuged preparations). Is adenocarcinoma more readily detected in liquid-based preparations? We reviewed responses from 16,750 fluid challenges of adenocarcinoma distributed in 2005 in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology (CAP NGC). OBJECTIVE: To compare the performance of body cavity fluid liquid-based preparations with adenocarcinoma to that in classic preparations in the CAP NGC. DESIGN: Responses for ThinPrep challenges were compared with classic preparations for exact match diagnoses of adenocarcinoma from pelvic washes, pleural fluid, pericardial fluid, and peritoneal fluids in the 2005 CAP NGC. RESULTS: A total of 13,690 pathologists, 8345 cytotechnologists, and 5958 laboratories submitted responses to fluid challenges in 2005. Adenocarcinoma comprised 16,750 of the fluid challenges; 88% were classic preparations, and 12% were ThinPrep challenges. The exact match to the reference diagnosis of adenocarcinoma was seen in 77% of conventional preparations and 81% of ThinPrep challenges when a general category of "positive for malignancy" was assigned. When "suspicious for malignancy," an exact match diagnosis of adenocarcinoma was made in 5% and 4% of classic and ThinPrep challenges, respectively. CONCLUSIONS: ThinPrep challenges performed slightly better overall, but only pelvic washings and peritoneal fluids demonstrated statistically significant improved performance with ThinPrep challenges. Use of liquid-based preparation is widespread for nongynecologic preparations and performs as well, and sometimes better than, classic preparations in an interlaboratory comparison program.
机译:背景:较新的液体制剂在形态上与经典制剂(涂片,过滤器和细胞离心制剂)不同。液体制剂中是否更容易检测到腺癌?我们回顾了2005年在Nongynecologic Cytology(CAP NGC)的美国病理学家间实验室比较计划中分配的16,750例腺癌液体挑战的反应。目的:比较CAP NGC中基于体腔液的腺癌与传统制剂的性能。设计:在2005 CAP NGC中,将针对ThinPrep挑战的反应与通过盆腔清洗,胸膜积液,心包积液和腹膜积液对腺癌进行精确匹配诊断的经典制剂进行了比较。结果:2005年共有13690位病理学家,8345位细胞技术专家和5958个实验室提交了对液体挑战的回应。腺癌包括16750液体挑战。 88%是经典制剂,12%是ThinPrep挑战。当指定了“恶性阳性”的一般类别时,可以在77%的常规制剂中和81%的ThinPrep挑战中看到与腺癌参考诊断的确切匹配。当“怀疑是恶性肿瘤”时,分别在经典和ThinPrep攻击中分别有5%和4%做出了腺癌的精确匹配诊断。结论:ThinPrep挑战总体上表现稍好,但只有盆腔清洗液和腹膜液在ThinPrep挑战中表现出统计学上显着改善的性能。基于液体的制剂广泛用于非妇科制剂,并且在实验室间比较程序中的性能也与传统制剂一样好,有时甚至优于传统制剂。

著录项

  • 来源
    《Archives of Pathology & Laboratory Medicine》 |2008年第11期|p.1716-1718|共3页
  • 作者单位

    Ann T. Moriarty, MD, Mary R. Schwartz, MD, Barbara S. Ducatman, MD, Christine N. Booth, MD, Jennifer Haja, CT(ASCP), Subhendu Chakraborty, MS, Beth Williamson, CT(ASCP)Accepted for publication March 19, 2008.From AmeriPath Indiana, Indianapolis (Dr Moriarty), the Cytopathology Resource Committee, College of American Pathologists, Northfield, Ill (Drs Moriarty, Schwartz, Ducatman, and Booth), the Department of Pathology, The Methodist Hospital, Houston, Tex (Dr Schwartz and Mr Chakraborty), the Department of Pathology, West Virginia University Hospital, Morgantown (Dr Ducatman), the Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio (Dr Booth), and the Surveys Department, College of American Pathologists, Northfield, Ill (Ms Haja and Ms Williamson).The authors have no relevant financial interest in the products or companies described in this articlePresented in part at the 55th Scientific Session of The American Society of Cytopathology, Houston, Tex, November 2007.Reprints: Ann T. Moriarty, MD, AmeriPath Indiana, 2560 N Shadeland Ave, Suite A, Indianapolis, IN 46219-1739 (e-mail: amoriarty@ ameripath.com).,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号